Australia markets closed

Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
10.35+0.14 (+1.37%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.42B
Enterprise value 3.79B
Trailing P/E 28.03
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.52
Price/book (mrq)2.90
Enterprise value/revenue 2.86
Enterprise value/EBITDA 23.60

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-22.69%
S&P500 52-week change 329.57%
52-week high 314.44
52-week low 36.81
50-day moving average 310.21
200-day moving average 312.36

Share statistics

Avg vol (3-month) 35.07M
Avg vol (10-day) 36.49M
Shares outstanding 5334.89M
Implied shares outstanding 6336.84M
Float 8119.07M
% held by insiders 166.48%
% held by institutions 12.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.35
Forward annual dividend yield 43.43%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 32.45%
5-year average dividend yield 42.23
Payout ratio 496.08%
Dividend date 3N/A
Ex-dividend date 431 May 2023
Last split factor 21.4:1
Last split date 331 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 9.01%
Operating margin (ttm)0.62%

Management effectiveness

Return on assets (ttm)3.41%
Return on equity (ttm)10.29%

Income statement

Revenue (ttm)1.33B
Revenue per share (ttm)4.06
Quarterly revenue growth (yoy)-13.00%
Gross profit (ttm)N/A
EBITDA 194.28M
Net income avi to common (ttm)119.41M
Diluted EPS (ttm)0.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)205.31M
Total cash per share (mrq)0.61
Total debt (mrq)575.18M
Total debt/equity (mrq)48.83%
Current ratio (mrq)1.97
Book value per share (mrq)3.52

Cash flow statement

Operating cash flow (ttm)237.39M
Levered free cash flow (ttm)-47.04M